Thermo Fisher Scientific
* Required field
Your research in cancer genomics makes a difference.
Reference: Ngeow J, Eng C. Precision medicine in heritable cancer: When somatic tumour testing and germline mutations meet. NPJ Genom Med. 2016;1:15006. PMID: 29263804. DOI: 10.1038/ npjgenmed.2015.6.
In recent years, significant technological improvements in sequencing and analysis tools have empowered researchers to get answers faster and more efficiently than ever before.
Targeted next-generation sequencing (NGS) is an accurate, fast, and precise approach suitable for analyzing multifactorial disorders with known or suspected variants such as cancer, diabetes, and hypertension.
Unlike other NGS approaches, our Ion Torrent focused NGS technology enables the speed, scalability, and precision researchers need to spend more time finding answers and less time looking for them.
Our Ion Torrent focused NGS solution for hereditary cancer genomics (CGx) provides:
** From DNA to variants, using the Ion Chef instrument with the Ion GeneStudio S5 systems.
For Research Use Only. Not for use in diagnostic procedures.